Last updated on June 2019

Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Septicemia | Critical Illness | Aspects of mortality statistics | Bacteremia | Mortality | Anti-Infective Agents | intensive care
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Patient is in ICU or under the care of ICU physician at the time the blood culture is drawn or reported as positive.
  2. Patient has a positive blood culture with pathogenic bacteria.

Exclusion Criteria:

  1. Patient already enrolled in the trial
  2. Patient has severe immune system compromise, as defined by: absolute neutrophil count <0.5x109/L; or is receiving immunosuppressive treatment for solid organ or bone marrow or stem cell transplant
  3. Patient has a prosthetic heart valve or synthetic endovascular graft
  4. Patient has documented or suspected syndrome with well-defined requirement for prolonged treatment:
  5. infective endocarditis; ii) osteomyelitis/septic arthritis; iii) undrainable/undrained abscess; iv) unremovable/unremoved prosthetic-associated infection
  6. Patient has a single positive blood culture with a common contaminant organism according to Clinical Laboratory & Standards Institute (CLSI) Guidelines: coagulase negative staphylococci; or Bacillus spp.; or Corynebacterium spp.; or Propionobacterium spp.; or Aerococcus spp.; or Micrococcus spp.
  7. Patient has a positive blood culture with Staphylococcus aureus or Staphylococcus lugdunensis
  8. Patient has a positive blood culture with Candida spp. or other fungal species.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.